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Background: The aim of the study was to analyze the effect of preoperative patient characteristics on health
outcomes 6 months after total hip replacement (THR), to support patient’s decision making in daily practice with
predicted health states and satisfaction thresholds. By giving incremental effects for different patient subgroups,
we support comparative effectiveness research (CER) on osteoarthritis interventions.
Methods: In 2012, 321 patients participated in health state evaluation before and 6 months after THR. Health-related
quality of life (HRQoL) was measured with the EQ-5D questionnaire. Hip-specific pain, function, and mobility were
measured with the WOMAC in a prospective observation of a cohort. The predictive capability of preoperative patient
characteristics – classified according to socio-demographic factors, medical factors, and health state variables – for
changes in health outcomes is tested by correlation analysis and multivariate linear regressions. Related satisfaction
thresholds were calculated with the patient acceptable symptom state (PASS) concept.
Results: The mean WOMAC and EQ-5D scores before operation were 52 and 60 respectively (0 worst, 100 best). At the
6-month follow-up, scores improved by 35 and 19 units. On average, patients reported satisfaction with the operation
if postoperative (change) WOMAC scores were higher than 85 (32) and postoperative (change) EQ-5D scores were
higher than 79 (14).
Conclusions: Changes in WOMAC and EQ-5D scores can mainly be explained by preoperative scores. The lower the
preoperative WOMAC or EQ-5D scores, the higher the change in the scores. Very good or very poor preoperative scores
lower the probability of patient satisfaction with THR. Shared decision making using a personalized risk assessment
approach provides predicted health states and satisfaction thresholds.
Keywords: Health-related quality of life, EQ-5D, WOMAC, Total hip replacement, Satisfaction, Patient acceptable
symptom stateBackground
Total hip replacement (THR) is an effective operation
that relieves pain and improves function, mobility, and
health-related quality of life (HRQoL) in patients with
osteoarthritis and further diagnoses [1-4]. As hip re-
placement rates are increasing greatly worldwide [5,6],* Correspondence: matthias.vogl@helmholtz-muenchen.de
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unless otherwise stated.precise advice for patients with expectancy values for
health outcomes and satisfaction thresholds is essential
[7]. Thus, besides physician evaluation, a patient-based
evaluation of generic and disease-specific health state
changes by THR is necessary [4,8]. Therefore, EQ-5D and
WOMAC (Western Ontario and McMaster Universities
Arthritis Index) questionnaires are recognized as the most
reliable, valid, and responsive in the literature [9,10]. Espe-
cially in the German context, it is not yet known if this ap-
plies to all patient groups and whether these patients are
actually satisfied with usually positive health outcomes
after THR. Thus, we analyze health outcomes and related
satisfaction for the first time in a German prospectived. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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benefit of THR can be supplemented by this health
economics and medical analysis with patient-based gen-
eric quality of life (EQ-5D) and disease-specific function/
mobility/pain questionnaires (WOMAC). Patient charac-
teristics and preoperative health scores are used to calcu-
late the patient group-specific, expected value of THR. As
our primary objective was to provide patient and clinician
support in day-to-day routines of shared decision making,
total knee replacement as a comparative procedure was
not included in our analysis.
The integrative aspect of health outcome and satisfac-
tion analysis gains importance for two reasons: (1) Shared
decision making by patient and clinician – by using a
personalized risk assessment approach – is becoming an
important challenge to satisfy the patient [11]. This study
gives patient group-specific information on average im-
provements in health outcomes and their time horizon
to supply an empirical basis for shared decision making
in THR. The study facilitates patient information and
supports a patient’s decision making in daily practice by
comprehensive measures of health outcomes and satisfac-
tion threshold values. To define the actual value of an
intervention for the patient, and make it applicable to the
patient, the practitioner, and health policy, an exact know-
ledge of health outcome drivers is necessary [12]. (2) This
study calculates incremental effects for different patient
subgroups to inform future intervention studies, cost-
effectiveness analyses, modeling approaches, or payment
by results in THR. For comparative effectiveness research
(CER) on osteoarthritis interventions, a grouping and dis-
tribution information for preoperative variables that affect
health outcome is generated [13]. Thereby, we question
gains in health outcomes for several patient groups.
We used a virtually exhaustive set of patient character-
istics that have been shown previously to impact patient
outcome in clinical studies [2], as well as information on
common side diagnoses, comorbidities, and procedures.
There is a research gap on the impact of preoperative
patient characteristics on generic health outcomes, use-
ful for understandable patient information and economic
analysis of cost-effectiveness and benefit for defined pa-
tient groups, e.g., results inform about the probability of
and time until a health state is better than before the
operation.
The first aim of the study is to analyze the effect of pre-
operative patient characteristics on postoperative HRQoL,
hip-specific pain, and function/mobility to be able to
group patients for individual decision making based on
the strongest predictors for health outcome changes. This
facilitates patient information on surgery outcome and
enables economic analysis of total hip replacement (THR)
in different patient groups. To evaluate clinically rele-
vant improvements and postoperative states the patient issatisfied with in daily practice, the patient acceptable
symptom state (PASS) concept is used [14]. For THR, the
PASS concept is a validated instrument in the litera-
ture [15,16]. It gives a threshold value beyond which
patients define their health state as well or are actu-
ally satisfied with the results of THR [14]. 6 months
after the operation patients reported health outcomes
and were asked whether they were satisfied with
THR. Satisfaction results were linked to their postop-
erative health outcome scores, to be able to support
patients in day-to-day routines on their decision on
THR with meaningful and appraisable expected health
outcome changes from the perspective of the patient,
the main objective of this study.
Patients and methods
Study design
The study was designed as a single center, prospective
observation of a cohort. Dependent variables were the
change in HRQoL scores (EQ-5D) and hip-specific pain
and function/mobility scores (WOMAC). The study used
6 months for follow-up, as prior studies have shown that
most health improvements are reached within this period
[15]. The 6-month time horizon is more imaginable and
meaningful for a shared decision making situation with
the patient than a later follow-up. However, this implies
that the patient should be informed that the scores slightly
underestimate the improvements by THA after a year
or even three years as especially the function scores will
still slightly improve after the 6-month time horizon. Pre-
dictive patient characteristics analyzed were separated
into three subdomains: (1) socio-demographic factors;
(2) medical factors; (3) HRQoL, pain, function, and mo-
bility before THR (Table 1). This virtually exhaustive set of
patient characteristics has been shown previously to im-
pact patient outcome in clinical studies [2]. Essential for
the observational study design was that all patients were
treated similarly according to their major diagnosis, inde-
pendent of their preoperative characteristics [17].
Recent studies refer to minimum clinically important
differences (MCID) or patient acceptable symptom state
(PASS) to define clinically relevant states for the pa-
tient [7,14,18,19]. As we want to define cut-off values
of WOMAC or EQ-5D scores that are associated with
patient satisfaction in THR and not only with a signifi-
cant change in WOMAC or EQ-5D scores, two well
established PASS methods were used: to calculate be-
yond which health state the patients are satisfied with
THR outcome (“Were your expectations on THR ful-
filled?”), we calculated PASS scores with the 75th centile
method and the receiver operating characteristic (ROC)
curve method [20]. Thereby, PASS is an anchor to provide
more meaningful patient information and to help in inter-
preting health state results for patients and clinicians.
Table 1 Predictive patient characteristics
Significant Spearman’s rank correlation (p < 0.05): relation of patient characteristics
to WOMAC and EQ-5D VAS score *preoperative ^change °postoperative
Frequency/mean (SD) %
Side diagnoses, at least 10 times in study patients
D62 - acute anemia*^° 25 8.5
E03 - hypothyroidism 47 16.7
E11 - diabetes*° 23 8.2
E66 - obesity*^° 17 6.0
E78 - lipidemia 27 9.6
E79 - purine/pyrimidine metabolism 13 4.6
E86 - hypovolemia 13 4.6
E87 - dysfunction of water/electrolyte balance 17 6.0
F32 - depression 11 3.9
I10 - arterial hypertonicity 155 55.2
I25 - ischemic heart disease 15 5.3
I48 - atrial fibrillation 10 3.6
J45 - asthma 11 3.9
N18/N39 - renal failure and related diseases 17 6.1
Z88 - drug allergy* 14 5.0
Z91 - risk factors in personal anamnesis* 14 5.0
Z92 - care of personal anamnesis° 39 13.9
Z95 - cardiac/vascular implants 23 8.2
Z96 - other functional implants° 42 14.9
n.n. - cardiopathy 25 8.9
n.n. - COPD 11 3.9
n.n. - hypercholesterolemia 41 14.6
n.n. - myocardial infarction/stent 18 6.4
n.n. - reflux^ 17 6.0
n.n. - major hip distortion^ 20 7.2
n.n. - deep venous thrombosis (DVT) 12 4.3
Number of side diagnoses*° 3.6 (2.9)
Operations and procedures, at least 5 times in study patients
5-791 - open reposition of fracture 5 1.8
5-829 - other arthroplasty*^ 8 2.8
5-986 - minimally invasive technique 270 96.1
8-919 - acute pain relief 5 1.8
8-930/1 - monitoring 26 9.3
Number of operations and procedures* 2.4 (1.1)
Other
Age° 67.7 (10.1)
Gender male*^° 117 41.6
BMI* 26.9 (4.9)
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Table 1 Predictive patient characteristics (Continued)
Operations at joint before procedure°
0 263 93.9
1 12 4.3








With partner 141 50.2
With family 58 20.9
Discharge home (others inpatient rehabilitation)° 53 18.8
Health insurance compulsory (others private)*° 136 48.4
Already THR° 58 20.6
Preoperative hemoglobin*^° 14.1 (1.2)









3 or higher 7 2.5
Metabolic syndrome (yes)*° 8 2.7
Cement (cement or hybrid)* 33 11.8
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From January 2012 to June 2012, 387 patients at BBM
Clinic participated in the health state evaluation before
THR at the admission day and 321 also participated in the
follow-up evaluation 6 months after discharge (Figure 1).
Patients lost to follow-up did not differ significantly in
most baseline characteristics. However, they had a statisti-
cally significantly lower preoperative WOMAC score
(−5.2) and EQ-5D score (−3.4). There were no exclusion
criteria except missing patient consent. Besides patientsFigure 1 Flow chart on patients included.with the major diagnosis of osteoarthritis of the hip, the
study also included individuals with osteonecrosis. As we
excluded revision THR, we had no mechanical complica-
tions or infections for major diagnoses. The study had ap-
proval from the ethics commission of Klinikum rechts der
Isar, Technical University Munich.
Measuring instruments
According to clinical practice guidance, pain, function/
mobility, and HRQoL are limitations related to major
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with the EQ-5D, a generic instrument that generates an
index value with a standard formula out of five dimen-
sions: mobility, self-care, usual activity, pain/discomfort,
and anxiety/depression [23]. Each dimension has three
possible levels to report current problems: no problems,
some problems, and severe problems. To assign an over-
all value to each of the possible 253 health states, two
standardized formulas are used [23,24]. To enable com-
parison with former studies and provide a basis for mod-
eling purposes (e.g., for QALY calculation), we provide
HRQoL outcomes based on the widely used UK popula-
tion preference-weighted EQ-5D index values [24,25]. To
respect actual experiences in the German population, we
use a recently developed German population experience-
weighted EQ-5D index [23]. The EQ-5D VAS that mea-
sures the overall health state was completed by the study
population as the gold standard. The EQ-5D score is a
qualified and well recognized health outcome measure in
patients who receive THR: it has been tested for its valid-
ity, reliability, and responsiveness in relation to the SF-36,
SF-6D, WOMAC, and Oxford Hip Score [9,26].
To measure hip-specific outcome from the patients’ view,
we use the WOMAC with its three subscales on pain (five
sub-questions), stiffness (two sub-questions), mobility
(17 sub-questions), and an overall score based on the
three subscales. The sub-questions used a Likert scale from
0 to 10. The questionnaire showed the best psychometric
characteristics for hip and knee replacement patients in
disease-specific questionnaires [10] and has also been
tested for its validity in the German version [27,28]. We
normalized each score into a 0–100 scale, with 0 being the
poorest and 100 being the best possible score, to improve
comparability. Satisfaction with THR was measured using
a Likert scale from 0 to 10, with 9 and 10 defined as satis-
fied with THR. In the following we additionally provide
change scores besides pre- and postoperative scores to
support patient comprehension in day-to-day routines.
Statistical analysis
We provide descriptive statistics on the distribution of
postoperative scores and corresponding change scores,
and examined bivariate association with preoperative pa-
tient characteristics, using Spearman’s rank correlation.
In case Spearman’s correlation is significant (p < 0.05), vari-
ables were considered as potential covariates for multivariate
ordinary least squares (OLS) regression analyses. Statistical
significance was assumed with p < 0.05. A power calculation
(alpha = 0.05) for repeated measures of WOMAC and
EQ-5D analyses showed an observed power of 1. The final
set of covariates was determined using a backward selec-
tion method based on significance in regression analysis.
When comparing the health outcomes of preoperative
EQ-5D and WOMAC groups, it has to be borne in mindthat we use an observational study design where a regres-
sion to the mean effect is possible [29].
In determining clinically relevant health state changes
(PASS), we were especially interested in the very satis-
fied group, as these estimates are not yet available and
literature demands cut-off values for the highest levels
of satisfaction [30] (Figure 2 and Figure 3). The ROC curve
was used to identify satisfaction cut-off values for changes
and 6-month postoperative WOMAC and EQ-5D scores.
The ROC curve displays sensitivity/specificity pairs, where
each corresponds to a possible cut-off value. We defined
the optimal cut-off value where the difference in sensitivity
and specificity is minimized. The area under the ROC
curve (AUC) measures how well preoperative EQ-5D and
WOMAC values separate between satisfied and unsatisfied
patients. The closer the AUC is to 1 (the better it fills the
upper triangles in Figure 3), the better EQ-5D and
WOMAC can distinguish between satisfied and unsatisfied
patients. Distribution functions of satisfied and unsatisfied
patients were generated to show at which WOMAC or
EQ-5D state their functions differentiate and to validate
ROC curve results [16,20] (75th centile method). The 75th
centile method calculates health state values reached by
75% of the satisfied/unsatisfied patients (Figure 2).
Results
Health outcomes
The average age of patients was 68 years, 58% were fe-
male, and most patients had few general diseases (ASA 1
or 2 and Charlson Comorbidity Index 0 or 1). Some 21%
of the patients already had a hip replacement at the
opposite side. Table 1 gives an overview of all control
variables: significant associations with the changes and
postoperative WOMAC and EQ-5D scores were observed
for acute anemia, major hip distortion, BMI, preoperative
hemoglobin, Charlson Comorbidity Index, etc. (Table 1).
Variance in health outcome changes was mainly ex-
plained by preoperative WOMAC and EQ-5D scores. A
correlation matrix has shown high correlation of pre-
operative scores with score changes, 6-month follow-up
scores, and weeks until a health state better than pre-
operative was achieved. Average WOMAC score and
EQ-5D VAS before operation were 52 and 60 (0 worst,
100 best). Six months after THR, they had improved by
35 and 19 units (Figure 4 and Table 2). WOMAC and
EQ-5D subscales improved accordingly. The poorer the
preoperative WOMAC or any EQ-5D score, the higher
the change in the scores. Patients with still acceptable
preoperative scores had only slightly better postoperative
scores compared with patients with poor preoperative
WOMAC and EQ-5D scores (Figure 4 and Table 2). On
average, 2% of THR patients described their health state,
pain, and mobility as worse than before the procedure,
about 6% described it as similar, 29% as better, and
Figure 2 Distribution function to determine patient acceptable symptom state (PASS) with 75th centile method. Figure legend: ∙∙∙∙∙
unsatisfied patients ── satisfied patients.
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correlated with WOMAC and all EQ-5D scores. Within
EQ-5D dimensions, especially pain/discomfort, usual ac-
tivity, and mobility improved for most patients (Additional
file 1). On average, it takes 10 weeks until health state or
daily routine is better than before the operation, 5 weeks
until pain is better, and 8 weeks until mobility is better
than before the operation (Table 3). The time until daily
routine is better than before the operation decreases with
a high preoperative WOMAC or EQ-5D score. With the
patient characteristics analyzed, it was impossible to pre-
dict the time until pain or mobility was better than before
the operation for different subgroups.
After multivariate regression analyses, we see that about
68% of the variance of changes in WOMAC and 47% of the
variance of changes in EQ-5D VAS can be explained by
very few preoperative patient characteristics: preoperative
WOMAC and EQ-5D VAS scores, ASA score, metabolic
syndrome, etc. (Table 4). When performing multivariate
analysis with and without preoperative scores, we see that
75% of the explained variance is explained by the preopera-
tive WOMAC score in the WOMAC change score model,
and for the EQ-5D VAS change score model, 81% of the
explained variance is explained by the preoperative EQ-5D
VAS score. Thus, the change in WOMAC and EQ-5D can
be well explained by preoperative WOMAC and EQ-5D
only. Special risk groups or patient groups in which THR
had no positive effect on WOMAC or EQ-5D scores could
not be detected. Based on our statistical analyses, patients
who do not benefit from THR cannot be identified by pre-
operative socio-demographic, medical, and health state
characteristics.Satisfaction outcomes
PASS estimates based on the ROC curve method and the
75th centile method were very similar. ROC curve esti-
mates (Figure 3) of patients who considered their health
state as satisfactory were above 85 for postoperative
WOMAC (sensitivity 77%, specificity 77%), above 32 for
change in WOMAC, above 79 for postoperative EQ-5D
VAS (sensitivity 79%, specificity 70%), and above 14 for
change in EQ-5D VAS. Sensitivity analyses on the satisfac-
tion Likert scale, calculating cut-off values including 8, 9,
and 10 or only 10 as the satisfactory state, show stable cut-
off values. When only 10 is measured as satisfactory, cut-off
values for 6-month postoperative states are 2 points higher;
when 8 is included, cut-off values do not change. 75th cen-
tile estimates show similar results: of patients who consid-
ered their state satisfactory, 75% had a change in WOMAC
of more than 25 (CI ±2). The satisfied patients had a postop-
erative WOMAC score above 86 (CI ±1). Concerning EQ-
5D VAS change, 75% of the satisfied patients noted a change
of 8 or higher (CI ±3). They had a postoperative EQ-5D
VAS state of 80 or higher (CI ±3) (Figure 2).
Socio-demographic and medical covariates for satis-
fied and unsatisfied patients did not vary with PASS
values of both WOMAC and EQ-5D VAS, while preopera-
tive WOMAC and EQ-5D VAS scores correlated with
PASS (p < 0.01) [20,30]. PASS outcomes show low prob-
ability of satisfaction for patients with WOMAC changes
of less than 25 and EQ-5D VAS changes of less than 8.
These patients have average preoperative WOMAC and
EQ-5D VAS scores of 67 and 73 compared with 45 and
54 for the satisfied patients. Patients with postopera-
tive WOMAC below 86 and EQ-5D VAS below 80
Figure 3 ROC curve using satisfaction and postoperative
WOAMC/EQ-5D VAS scores.
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have average preoperative WOMAC and EQ-5D VAS
scores of 45 and 51 compared with 56 and 64 for the satis-
fied patients. This suggests that health outcome and pre-
operative health scores are related to satisfaction after
THR: very poor and very good preoperative scores correl-
ate with low satisfaction.
Discussion
Health outcomes
This study contributes to the literature of predictors of
postoperative health outcomes after THR and the litera-
ture on predicting satisfaction after THR by investigatingboth subjects integrative in the German context. Related
studies are by trend conform to our study [3,7,31-33]. THR
outcome was mainly related to preoperative WOMAC
and EQ-5D scores. There was a high correlation between
WOMAC and EQ-5D scores, showing that the WOMAC
results of THR patients can explain large parts of HRQoL,
and that EQ-5D is a responsive instrument for THR pa-
tients. Although socio-demographic and medical covari-
ates showed correlation with change and postoperative
WOMAC and EQ-5D scores (Table 1), their contribution
to the explanation was very low in multivariate models
once the preoperative WOMAC and EQ-5D scores are
accounted for (Table 4). Other studies were inconclusive
on the impact of other preoperative variables than health
state scores on postoperative health outcomes [2,3]. That
predictability is highest with preoperative scores is in
accordance with studies by Fortin et al., Röder et al., and
Hawker et al. [7,32,34].
The separation of the most predictive variables (WOMAC
and EQ-5D preoperatively) to support individual patient
information and decision making showed that, for all
groups, a significant improvement in WOMAC and HRQoL
scores can be reached. The improvement is lowest in the
group with still acceptable preoperative WOMAC scores
(81–100) and acceptable preoperative EQ-5D scores (71–
100). According to clinical practice guidance, conservative
therapy is useful when pain is still low and there are minor
limitations in function/mobility and HRQoL. Afterwards
there is an optimal time slot for THR where health out-
comes and satisfaction are best. This conforms with the
study results showing that patients with still acceptable
preoperative WOMAC and EQ-5D scores have a tendency
to benefit less from THR and also have a lower probability
of being satisfied, as possible improvements from THR
are lower (Figure 4). For patients with poorest scores,
who also have a tendency to benefit less from THR, con-
servative therapy is no longer an option, questioning the
use of THR only for patients in the group of still accept-
able WOMAC or EQ-5D scores.
Satisfaction outcomes
In direct comparison to PASS results by Anakwe et al.,
Escobar et al., and Kvamme et al., we calculated a higher
satisfaction threshold for EQ-5D and WOMAC scores
as our baseline and follow-up scores of WOMAC and
EQ-5D were higher [15,35,36]. Anakwe et al. showed that
unlike postoperative scores, preoperative function scores
are not related to satisfaction [35]. Several other studies
found that WOMAC [7,15,16,35,36] and EQ-5D [36] post-
operative scores can be related to a PASS. As a prediction
of PASS satisfaction measures to support patient’s choice
on THR does not yet exist, we used an indirect way to
predict satisfaction for the patient preoperatively: we re-
lated satisfaction measures to postoperative and change
Figure 4 WOMAC sum and EQ-5D VAS boxplots. The horizontal lines correspond to the satisfaction thresholds (75th centile method).
Satisfaction is assumed at a 9 or 10 on a 0–10 satisfaction Likert scale.
Vogl et al. Health and Quality of Life Outcomes 2014, 12:108 Page 8 of 12
http://www.hqlo.com/content/12/1/108scores that can be expected by the classification of a pa-
tient into the given preoperative WOMAC and EQ-5D
score groups.
The classification into preoperative EQ-5D and WOMAC
groups and related satisfaction thresholds allows informed
decision making on THR when included in preoperative
patient information [30]. Presenting the patient’s expected
WOMAC and EQ-5D outcomes in a boxplot, separated
by preoperative scores can facilitate patient choice when
preoperative WOMAC and EQ-5D scores are calculated
for the patient (Figure 4 and Additional file 2). In this
study, satisfaction thresholds are given for the first time
for the highest levels of satisfaction, and for WOMAC and
EQ-5D changes and 6-month follow-up states. Besides
this patient information, the introduction of standardized
performance measures from a patient’s perspective also
has management relevance concerning marketing at the
patient or practitioner level.Strengths and weaknesses
Strengths of the study are the large patient group reached in
a short period in a single hospital – allowing a distribution
of the predictive factors – and the nearly exhaustive set of
control variables analyzed simultaneously. Modelers benefit
from preoperative EQ-5D and WOMAC distribution infor-
mation. The distribution information on WOMAC and
EQ-5D (Table 4) enables a transformation of WOMAC
values into EQ-5D values, allowing (cost-)utility calcula-
tions with quality-adjusted life years (QALY) for studies
that used WOMAC only. Another advantage is the con-
duct of the study in a standard supply hospital with a large
catchment area to get a cross-section of patients and avoid
preselection concerning, e.g., comorbidity [37]. On the
other hand, generalizability of study results might not be
given, as we used a single hospital to include only patients
treated identically according to their medical need. Where
applicable, patients were operated with minimally invasive
Table 2 Changes in WOMAC and EQ-5D
0 worst, 100 best Pre-operative 6 months follow-up Change
Preoperative Mean SE Mean SE Mean SE N
WOMAC pain 55.6 1.1 90.4 0.8 34.7 1.2 281
0-20 12.9 1.3 89.0 2.1 76.1 2.2 14
21-40 33.1 0.8 85.7 2.4 52.6 2.6 45
41-60 51.4 0.5 87.8 1.4 36.4 1.4 110
61-80 70.8 0.6 94.9 0.8 24.1 1.0 89
81-100 87.7 1.0 95.3 1.2 7.7 1.6 23
WOMAC stiffness 46.6 1.4 83.0 1.0 36.5 1.5 281
0-20 14.1 0.8 79.1 2.5 65.0 2.7 56
21-40 33.2 0.7 81.1 2.2 48.0 2.3 66
41-60 53.4 0.6 82.2 2.0 28.8 2.0 86
61-80 71.9 0.8 87.8 1.6 15.8 1.9 60
81-100 91.9 1.3 93.1 3.1 1.2 2.5 13
WOMAC function 51.3 1.1 86.7 0.8 35.5 1.1 281
0-20 16.4 1.0 79.4 3.1 63.4 3.4 21
21-40 33.6 0.6 78.8 2.1 45.3 2.2 69
41-60 50.5 0.6 88.1 1.2 37.5 1.3 96
61-80 69.4 0.6 92.2 0.8 22.8 1.1 77
81-100 85.9 1.0 94.9 1.2 9.0 1.3 18
WOMAC sum 51.8 1.1 86.7 0.8 34.9 1.1 281
0-20 15.2 1.4 84.2 1.7 69.0 2.2 14
21-40 33.7 0.6 79.6 2.1 45.9 2.2 71
41-60 51.2 0.6 87.4 1.2 36.2 1.3 108
61-80 70.3 0.7 91.6 1.0 21.3 1.2 73
81-100 85.4 0.9 93.9 1.3 8.5 1.3 15
EQ-5D index* 53.9 0.9 76.9 0.9 22.9 1.0 281
0-40 33.1 0.5 70.1 2.1 37.1 2.1 69
41-50 46.8 0.3 76.2 2.2 29.3 2.1 41
51-60 54.2 0.2 76.4 1.7 22.2 1.8 70
61-70 65.5 0.3 80.7 1.4 15.3 1.5 53
71-100 76.9 0.6 83.5 1.4 6.7 1.6 48
EQ-5D index** 51.4 1.8 84.7 1.1 33.3 1.8 281
−40 8.8 1.1 79.4 2.5 70.5 2.3 88
41-50 - - - - - - -
51-60 56.8 0.6 85.4 3.3 28.6 3.0 26
61-70 66.6 0.3 84.3 1.8 17.7 1.9 73
71-100 77.9 0.6 89.8 1.3 12.0 1.4 94
EQ-5D VAS 59.6 1.2 78.4 1.1 18.8 1.4 281
0-40 28.0 1.3 74.7 2.8 46.7 2.6 57
41-50 48.3 0.4 70.1 3.4 21.8 3.4 49
51-60 58.4 0.5 74.1 2.8 15.7 2.9 37
61-70 68.8 0.3 81.5 2.5 12.8 2.6 52
71-100 81.9 0.8 85.4 1.3 3.5 1.3 86
*German population experience-weighted.
**UK population preference-weighted.
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Table 3 Weeks until effect was reached and general effect 6 months postoperatively
Weeks until effect was reached Daily routine Pain Mobility
Weeks mean 9.6 5.1 8.1
Weeks SD 5.4 4.9 5.2
Not yet better 6.0% 4.9% 5.6%
Effect 6 month postoperatively Frequency % Frequency % Frequency %
Much worse 0 0.0 0 0.0 3 1.1
Worse 7 2.6 3 1.1 5 1.8
Similar 21 7.7 7 2.6 18 6.6
Better 90 32.8 50 18.3 98 35.8
Much better 156 56.9 213 78.0 150 54.7
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http://www.hqlo.com/content/12/1/108technique. With patients needing uncemented arthroplasty
the Allofit cup/Spotorno stem system by Zimmer was used
as the standard, for hybrid systems a similar cup and a
Müller Straight stem by Zimmer was used, and for cemen-
ted systems a Müller PE cup and a Müller Straight stem
was used as the standard. Case numbers for other arthro-
plasty techniques than minimally invasive or for prosthesis
types were too low in the subgroups to find statistically
significant differences.
Weaknesses of the study are: (1) the low patient num-
ber in some subgroups that did, e.g., not allow to go into
a further detailed analysis of operation techniques andTable 4 Multivariate linear regression
Preoperative values Ch
*p < .05 **p < .01 (a
Co
Constant **
WOMAC pain score **
WOMAC stiffness score **
WOMAC function score **
EQ-5D usual activity severe problems compared to none **
EQ-5D anxiety/depression some problems compared to none **
EQ-5D visual analog scale (VAS)
major hip distortion −4
E11 - diabetes −6
E66 - obesity 5.7
Z96 - other functional implants *-
5-829 - other arthroplasty
Reflux **
Number of operations and procedures −1
Housing situation family compared to alone −1
Discharge home compared to inpatient rehabilitation 3.5
ASA 2 compared to 1 **
Discharge home compared to inpatient rehabilitation
Metabolic syndrome **prosthesis type used; (2) that socio-economic variables were
limited to compulsory and private health insurance, differ-
entiating roughly between high and low income patients.
Here we would expect differences in socio-economic
groups, as a difference in health outcome between com-
pulsory and private insurance could already be detected;
(3) that more patients with lower a health state did not
participate in follow-up, although a lower preoperative
health state in WOMAC and EQ-5D is related to a higher
than average health improvement; (4) p-values in Table 4
are of restricted validity as we had to specify and estimate
on the same dataset – a split-sample design was notange in WOMAC sum Change in EQ-5D VAS
dj.R2 = 0 .68) (adj.R2 = 0.47)
efficient SE Coefficient SE
98.307 6.455 **77.959 10.141
-0.166 .062 -.189 .099
-0.191 .042
-0.536 .068 .185 .101
-47.200 11.407
-4.454 1.598 *-5.820 2.563
**-0.797 .064











-13.752 5.147 **-22.776 6.432
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http://www.hqlo.com/content/12/1/108reasonable due to the limited number of cases and would
have supported validity of results; and (5) we did not cal-
culate special PASS values for patients in each preopera-
tive WOMAC and EQ-5D index score group besides the
overall PASS score, as we did not have enough observa-
tions in each category to calculate a special PASS value in
each group with either the ROC curve method [16] or the
75th centile method [14]. By getting similar PASS cut-off
values with both methods and similar cut-off values within
a sensitivity analysis for the satisfaction measure, we ex-
pect to have robust results for the satisfaction thresholds
of WOMAC and EQ-5D. However, as patients with dif-
ferent preoperative health states might have different
perceptions on their satisfaction threshold, this subgroup
analysis should be researched in the future.
A future perspective
Change and postoperative HRQoL and WOMAC scores
are useful performance or patient value measures that can
be used as quality indicators in pay for performance sys-
tems [12]. In case WOMAC and EQ-5D change scores are
used as additional influencing factors for performance-
related reimbursement, the WOMAC is the preferred
instrument, as it is less influenced by comorbidities not
related to THR and has higher correlation with the pre-
operative score. Future research should match pre- and
postoperative EQ-5D values with population normative
values to further quantify the utility of THR for each pre-
operative EQ-5D group. The study allows a combination
of HRQoL measures with costing data at patient level,
supporting national and international comparison of ef-
fects and cost-effectiveness based on preoperative EQ-5D
scores. By giving incremental effects for different patient
subgroups, we support future comparative effectiveness re-
search on osteoarthritis interventions and across countries.
The National Health Service (NHS) in England has already
introduced the EQ-5D questionnaire as a standardized
questionnaire for a patient-reported outcome measure
(PROM), to be able to measure hospital performance and
cost-effectiveness for patient groups. A comparison of EQ-
5D changes with English values [38] on a patient basis can
show how routine data collection of health outcomes can
be introduced in further countries. To provide patients not
only with short term expectations (6 months) on health
outcomes, quality of life, and satisfaction, a second follow-
up period at 24 or 36 month should be provided for long
term expectations as especially function scores still slightly
improve after 6 months [2].
Conclusions
Changes in WOMAC and EQ-5D scores can mainly be
explained by preoperative scores. Other covariates con-
tributed only marginally to predict THR health out-
comes. Based on the PASS concept, very good or verypoor preoperative scores lower the probability of patient
satisfaction with THR. However, a patient group in
which HRQoL or WOMAC scores could not be im-
proved or a patient group that was unsatisfied could not
be detected. THR should not be restricted to subgroups,
as all subgroups can benefit. Shared decision making
using a personalized risk assessment approach provides
predicted health states and satisfaction thresholds to pa-
tients and can support the individual decision on THR.
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